Surgical was Enovis’s largest segment in fiscal 2025, bringing in $1.15B of $3.42B (34%).
| Business Segments | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2017 | FY 2018 | FY 2019 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Welding & Cutting | — | — | — | — | |||||||||
| Consumables | — | — | — | — | |||||||||
| Consumable Products | — | — | — | — | |||||||||
| Air & Gas Handling | — | — | — | — | |||||||||
| Gas Handling | — | — | — | — | |||||||||
| Prevention Recovery | — | — | — | — | |||||||||
| Fluid Handling | — | — | — | — | |||||||||
| Equipment | — | — | — | — | |||||||||
| Equipment Products | — | — | — | — | |||||||||
| Bracing & Support | $874.57M | $912.26M | $938.63M | $972.48M | |||||||||
| Surgical | $740.35M | $852.81M | $1.01B | $1.15B | |||||||||
| Prevention Recovery: | — | $701.64M | $715.80M | $758.19M | |||||||||
| Prevention & Recovery | $670.07M | — | — | — | |||||||||
| Other Prevention & Recovery | $510.61M | $539.65M | $541.48M | $543.27M | |||||||||
| Reconstructive | — | — | — | — | |||||||||
| Total | $2.80B | $3.01B | $3.21B | $3.42B |
Enovis brought in $3.42B from its four segments in fiscal 2025, the year ended December 31, 2025. That was up 6.7% from $3.21B in fiscal 2024. Surgical was the largest at $1.15B (33.5%), ahead of Bracing & Support at $972.48M (28.4%) and Prevention Recovery: at $758.19M (22.2%). The remaining segment, Other Prevention & Recovery, brought in $543.27M.
Compared with fiscal 2024, Surgical grew fastest, up 13.4% to $1.15B. Every segment above 2% of revenue grew.
Enovis began breaking out Prevention Recovery: in fiscal 2023, when it brought in $701.64M. Enovis stopped reporting Prevention & Recovery as a separate segment after fiscal 2022, when it brought in $670.07M.
Reconstructive: was Enovis’s largest segment in fiscal 2025, bringing in $1.15B of $2.12B (54%).
| Statement Business Segments | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fabrication Technology | — | — | — | — | ||||||||||
| Gas & Fluid Handling | — | — | — | — | ||||||||||
| Air & Gas | — | — | — | — | ||||||||||
| Medical Technology | — | — | — | — | ||||||||||
| Prevention Recovery: | — | $912.26M | $938.63M | $972.48M | ||||||||||
| Prevention & Recovery | $874.57M | — | — | — | ||||||||||
| Reconstructive: | — | $852.81M | $1.01B | $1.15B | ||||||||||
| Reconstructive | $740.35M | — | — | — | ||||||||||
| Total | $1.61B | $1.77B | $1.95B | $2.12B |
Enovis brought in $2.12B from its two segments in fiscal 2025, the year ended December 31, 2025. That is less than the $3.42B it reports by business segments, so these segments do not cover all of its revenue. Reconstructive: was the largest at $1.15B (54.1%), ahead of Prevention Recovery: at $972.48M (45.9%).
Compared with fiscal 2024, Reconstructive: grew 13.4% to $1.15B and Prevention Recovery: grew 3.6% to $972.48M.
Enovis began breaking out Prevention Recovery: in fiscal 2023 and Reconstructive: in fiscal 2023. Enovis stopped reporting Prevention & Recovery ($874.57M in fiscal 2022) and Reconstructive ($740.35M in fiscal 2022) as separate segments.
International was Enovis’s largest region in fiscal 2025, bringing in $1.15B of $2.22B (52%).
| Geography | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Foreign Locations | — | — | — | — | ||||||||||
| Other Foreign Locations | — | — | — | — | ||||||||||
| Foreign | — | — | — | — | ||||||||||
| United States | $874.57M | $912.26M | $1.01B | $1.07B | ||||||||||
| International | $670.07M | $701.64M | $1.01B | $1.15B | ||||||||||
| Total | $1.54B | $1.61B | $2.02B | $2.22B |
Enovis brought in $2.22B from its two regions in fiscal 2025, the year ended December 31, 2025. That is less than the $3.42B it reports by business segments, so these regions do not cover all of its revenue. International was the largest at $1.15B (51.6%), ahead of United States at $1.07B (48.4%).
Compared with fiscal 2024, International grew 13.8% to $1.15B and United States grew 6.3% to $1.07B.
Enovis (ENOV) reports its revenue by business segments, by statement business segments and by geography. In fiscal 2025, Surgical was its largest segment, bringing in $1.15B (33.5% of the total), followed by Bracing & Support at $972.48M (28.4%).
Surgical was Enovis' largest segment in fiscal 2025, bringing in $1.15B, or 33.5% of the $3.42B total across its four segments.
International was Enovis' largest region in fiscal 2025, bringing in $1.15B, or 51.6% of the $2.22B total across its two regions.
Among Enovis' segments that make up at least 2% of revenue, Surgical grew fastest in fiscal 2025, up 13.4% from $1.01B to $1.15B.
Every figure comes from Enovis' annual financial filings, as reported. Each line keeps the name Enovis gives it, and years follow its fiscal calendar.
Enovis' revenue by business segments goes back to fiscal 2010, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.